US 10023627
Vascular endothelial growth factor fusion protein
granted A61KA61K38/00A61K38/18
Quick answer
US patent 10023627 (Vascular endothelial growth factor fusion protein) held by KOREA PRIME PHARM CO., LTD. expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- KOREA PRIME PHARM CO., LTD.
- Grant date
- Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00, A61K38/18, A61K39/395, A61P